Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (407)

Latest Posts

About This Stock More About This Stock
Hot Options Report For End Of Day - Wednesday, September 13
Article By: The Options Insider
Wednesday, September 13, 2017 4:36 PM EDT
The most active equity options and strikes for end of the day Wednesday: AAPL, GILD and BAC.
In this article: AAPL, GILD, BAC
Read
Biopharmaceuticals Portfolio In A Biotech Bull Market
Article By: Rod Raynovich
Tuesday, September 5, 2017 11:08 PM EDT
Biotech stocks broke through the July sector highs as tracked by major ETFs. However we are still about 25% off the July 2015 bubble highs but supported by good earnings fundamentals, strong technicals and potentially a seasonal strong Q4.
In this article: BMY, RHHBY, IBB, QQQ, AMGN, BIIB, GILD, XBI, ABBV, KITE, BLUE, FMI
Read
HH Biotech Bonanza: The Next Leg Up For Biotech Stocks
Article By: Tarun Chandra, CFA
Friday, September 1, 2017 8:05 PM EDT
The Biotechnology sector remains one of the top performing sectors this year with the benchmark Nasdaq Biotechnology Index of biotech stocks, as represented by the biotech ETF (IBB​), gaining 17% in the first half.
In this article: NVS, PFE, IBB, GILD, VRTX, XBI, XLV, ONCE, LABU
Read
M&A Theme Continues To Boost Biotech Stocks
Article By: Rod Raynovich
Wednesday, August 30, 2017 9:30 PM EDT
The prospect of more M&A boosts biotech stocks for a third day this week. The large cap based IBB was up 1.87% today and 6.48% over five days to $323.76 approaching its YTD high of $327.34.
In this article: IBB, GILD, XBI, KITE, BLUE Also: BMRN, INCY, SGEN, CLVS, VRTX, AGIO, PTLA
Read
Deep Purple
Article By: Marvin R Clark
Monday, August 28, 2017 10:06 PM EDT
Domestic energy stocks were slammed today. Exxon down 0.3% and Chevron down 0.4%. Refiner Valero Energy climbed 1.1 percent.
In this article: CVX, VLO, XOM, AMZN, GILD, WFM, UGA, PSX, KITE Also: AAPL, MSFT, FB, GOOGL
Read

PARTNER HEADLINES

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments